Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Pharma Industry News BioNTech to launch construction of mRNA-based vaccine facility in Africa BioNTech revealed plans to launch the construction of a manufacturing plant for mRNA-based vaccines in the African Union… bySrinathOctober 27, 2021
